Paul Hudson
Paul Hudson is the Chief Executive Officer of Sanofi, a global biopharmaceutical company. Under his leadership, Sanofi has made significant investments in China, particularly in biopharmaceutical manufacturing and innovation, including a recent €1 billion investment to expand its production capacity in the Beijing Economic-Technological Development Area. Hudson's commitment to enhancing healthcare solutions aligns with the growing demand for diabetes treatments and advanced medical technologies.
Born on Jan 01, 1967 (58 years old)
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Turkey | 1 | 6.00 | 0.07% | +0% | 84,339,067 | 58,528 | $720,000 | 500$ |
| Serbia | 1 | 8.00 | 0.07% | +0% | 8,737,371 | 5,904 | $55,000 | 37$ |
| Monaco | 1 | 8.00 | 0.10% | +0% | 39,242 | 40 | $7,800 | 8$ |
| Totals | 3 | 93,115,680 | 64,472 | $782,800 | 545$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Serbia:
Paul Hudson is the CEO of Sanofi and commented on the strategic importance of the acquisition of Bluprint.
8
Monaco:
Paul Hudson, CEO of Sanofi, stated that the acquisition represents a strategic leap forward in their rare diseases and immunology portfolios.
8
Turkey:
Paul Hudson is the President of FlyersRights who criticizes the lack of seat size adjustments in airlines despite increasing passenger sizes.
6
Switzerland:
Paul Hudson, the CEO of Sanofi, joined Vas Narasimhan in advocating for higher drug prices in Europe.
6
Monaco:
Paul Hudson is the CEO of Sanofi and his fixed annual salary is set to increase.
6
Switzerland:
Paul Hudson, the CEO of Sanofi, joined Vas Narasimhan in addressing the need for higher medication prices in Europe.
6
Switzerland:
Paul Hudson is the CEO of Sanofi and has joined Vasant Narasimhan in advocating for higher drug prices in Europe.
5
Slovenia:
Paul Hudson, the CEO of Sanofi, warns that low drug prices and bureaucracy in Europe are making the region less attractive for pharmaceutical investments.
6
North Macedonia:
Paul Hudson, the CEO of Sanofi, participated in the meeting and praised China's stable economic growth.
8
China:
Paul Hudson, the CEO of Sanofi, announced a significant investment in a new insulin production facility in Beijing, marking a major milestone for the company in China.
9